Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors
Nuclear Medicine Review · 20.04.2026 · 29
DOI: 10.5603/nmr.114542 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nuclear Medicine Review, online erschienen am 20.04.2026. Verfasst von Malgorzata Poniatowska-Roszkowska und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland. M.poniatowska94@gmail.com. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Organometallic Compounds, Octreotide, Radiation Dosage.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland. M.poniatowska94@gmail.com.
- Department of Nuclear Medicine, Pomeranian Medical University in Szczecin, Szczecin, Poland.
- Medical Artificial Intelligence Laboratory, Institute of Medical Sciences, University of Zielona Gora, Zielona Gora, Poland.
ORCID-Profile: Malgorzata Poniatowska-Roszkowska, Hanna Piwowarska-Bilska, Bożena Birkenfeld
Zitieren
APA
Poniatowska-Roszkowska, M., Piwowarska-Bilska, H., Roszkowski, M., & Birkenfeld, B. (2026). Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors. Nuclear Medicine Review, 29(0). https://doi.org/10.5603/nmr.114542
Vancouver
Poniatowska-Roszkowska M, Piwowarska-Bilska H, Roszkowski M, Birkenfeld B. Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors. Nuclear Medicine Review. 2026;29(0). doi:10.5603/nmr.114542
BibTeX
@article{PoniatowskaRoszkowska2026,
author = {Poniatowska-Roszkowska, Malgorzata and Piwowarska-Bilska, Hanna and Roszkowski, Mikołaj and Birkenfeld, Bożena},
title = {Interpatient and intrapatient variability in organ absorbed doses during [177Lu]Lu-DOTATATE therapy for neuroendocrine tumors},
journal = {Nuclear Medicine Review},
year = {2026},
volume = {29},
number = {0},
doi = {10.5603/nmr.114542}
}
EUVIMED